RICERCA ITALIANA     

Programmi di ricerca simili:

• 1 - RUOLO DELLE ISOFORME DI IGF-1 NELLO SVILUPPO E RIPARAZIONE DEL DANNO EPATICO.
• 2 - Machine perfusion, una strategia innovativa per la preservazione e l'utilizzo di fegati marginali per trapianto: dai modelli animali all'uomo per una validazione sperimentale e clinica mediante metodi bioanalitici integrati.
• 3 - PERFUSIONE MECCANICA CONTINUA NORMOTERMICA E SUBNORMOTERMICA VERSUS IPOTERMIA CONVENZIONALE A 4 C° NELLA PRESERVAZIONE EPATICA PER TRAPIANTO: ANALISI COMPLESSA MEDIANTE METODICHE BIOANALITICHE INTEGRATE SU MODELLI ANIMALI E SU FEGATI UMANI.
• 4 - Studio degli eventi pre-trascrizionali, trascrizionali ed epigenetici in corso di rigenerazione ed immunodepressione indotta da danno epatico acuto e cronico in modelli animali ed umani
• 5 - METABOLISMO LOCALE ED ESPRESSIONE GENICA: NUOVE PROSPETTIVE IN CHIRURGIA
• 6 - RUOLO DELLE CELLULE DENDRITICHE, DELLE CITOCHINE E DEGLI ORMONI STEROIDEI SESSUALI NELLA STORIA NATURALE DELLE MALATTIE EPATICHE CRONICHE
• 7 - Studio delle alterazioni molecolari e funzionali in lesioni preneoplastiche e neoplastiche epatiche con diversa capacità di progressione. Individuazione di nuovi marcatori diagnostici e prognostici e bersagli terapeutici
• 8 - MECCANISMI DI RIPARAZIONE DEL DANNO EPATICO MODULATI DA IGF1 E SUE ISOFORME NELLE MALATTIE CRONICHE DI FEGATO ED IN MODELLI SPERIMENTALI. Sviluppo di strategie terapeutiche basate sulla modulazione del sistema IGF1.
• 9 - Meccanismi di danno e protezione nel miocardio ischemico
• 10 - CONTROLLO DEL CICLO CELLULARE DA LIGANDI DI RECETTORI NUCLEARI

Classificazione scientifico-disciplinare

• Area scientifico disciplinare: Scienze mediche
  • PATOLOGIA GENERALE
  • MEDICINA INTERNA
  • GASTROENTEROLOGIA
  • CHIRURGIA GENERALE

Classificazione brevettuale

• CHEMISTRY; METALLURGY
  • BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF (biocides, pest repellants or attractants, or plant growth regulators, containing micro-organisms, viruses, microbial fungi, enzymes, fermentates or substances produced by or extracted from micro-organisms or animal material A01N63/00; food compositions A21, A23; medicinal preparations A61K; chemical aspects of, or use of materials for, bandages, dressings, absorbent pads or surgical articles A61L; fertilisers C05); PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS (preservation of living parts of humans or animals A01N1/02); MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (micro-biological testing media C12Q)
• HUMAN NECESSITIES
  • MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES (bringing into special physical form A61J [N: mechanical aspects]; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; compounds per se C01, C07, C08, C12N; soap compositions C11D; micro-organisms per se C12N) [C0203]

Classificazione geografica

• Regione: Piemonte

Bibliografia

1. Brancatisano R et al. I s radical hepatic surgery safe? Am J Surg 1998;175:161-163.
2. Jaeschke H. Preservation injury: mechanisms, prevention and consequences. J Hepatol 1996; 25:774-780.
3. Selzner M et al. Fatty liver in liver transplantation and surgery. Sem Liver Dis 2001; 21:105-113.
4. Serracino-Ingolg F, et al. Hepatic ischemia-reperfusion injury. Am J Surg 2001; 181:160-166.
5. Rosser GB et al. Liver cell necrosis: cellular mechanisms and clinical implication. Gastroenterol 1995; 108:252-275.
6. Bronk SF et al. Efflux of protons from acidic vesicles contributes to cytosolic acidification of hepatocytes during ATP depletion. Hepatol 1991; 14:626-633.
7. Gasbarrini A et al. Effect of anoxia on intracellular ATP, Na+, Ca2+, Mg2+, and cytotoxicity in rat hepatocytes. J Biol Chem 1992; 267:6654-6663.
8. Carini R et al. Alterations of cell volume regulation in the development of hepatocyte necrosis. Exp Cell Res 1999; 248:280-293.
9. Jassem W et al. The role of mitochondria in ischemia/reperfusion injury. Transplant 2002; 73:493-499.
10. Lentsch AB et al. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatol. 2000; 32:169-173.
11. Takeuki D et al. Interleukin 18 causes hepatic ischemia/reperfusion injury by suppressing anti-inflammatory cytochine expression in mice. Hepatol 2004; 39:699-710.
12. Domenicali M et al. Food deprivation exacerbates mitochondrial oxidative stress in rat liver exposed to ischemia/reperfusion injury. J Nutr 2001; 131:105-110.
13. Caraceni P et al. Rat hepatocytes isolated from alcohol-induced fatty liver have an increased sensitivity to anoxic injury. Hepatol 1997; 25:943-949.
14. Selzner N. et al. Protective strategies against ischemic injury of the liver. Gastroenterology. 2003;125:917-36.
15. Yellon DM et al. The preconditioning phenomenon. A tool for the scientist or a clinical reality. Circ. Res. 2000; 87: 543-550.
16. Murry CE et al. Preconditioning with ischemia: a delay of letal cell injury in ischemic myocardium. Circulation 1986; 74:1124-1136.
17. Bolli R. The late preconditioning. Circ Res 2000; 87:972-983.
18. Schulz R et al. Signal trasduction of ischemic preconditioning. Cardivasc Res 2001; 52:181-198.
19. Mubagwa K et al. Adenosine, adenosine receptors and myocardial protection: An updated overview. Cardiovasc Res 2001; 52:25-39.
20. Zaugg M et al. Volatile anesthetics mimic cardiac preconditioning by priming the activation of mitochondrial KATP channels via multiple signaling pathway. Aneshesiol 2002; 97:4-14.
21. R.Carini et al.. Recent insides on the mechanisms of liver preconditioning Gastroenterology 2003, 125:1480-1491.
22. Peralta C et al. Liver ischemic preconditioning is mediated by the inhibitory action of nitric oxide on endothelin. Biochem Biophys Res Commun 1996; 229:264-270.
23. Peralta C et al. Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion in the rat: role of nitric oxide and adenosine. Hepatol 1997; 25:934-937.
24. Yoshizumi T et al. Amelioration of the liver injury by ischemic preconditioning. Br. J. Surg. 85 (1998) 1636-1640.
25. Teoh N et al. Hepatic ischemic preconditioning in mice is associated with activation of NF-kB, p38 kinase, and cycle entry. Hepatol 2002; 36:94-102.
26. Yadav S et al. Ischemic preconditioning protects the mouse liver by inhibition of apoptosis through a caspase-dependent pathway. Hepatol 1999; 130:1223-1231.
27. Serafin A et al. Ischemic preconditioning increases the tolerance of fatty liver to hepatic ischemia-reperfusion injury in the rats. Am J Pathol 2002; 161:587-601.
28. Yamagami K et al. Heat shock preconditioning ameliorates liver injury following normothermic ischemia-reperfusionin steatotic rat livers. J Surg Res 1998; 79:47-53.
29. Ito K et al. Doxorubicin preconditioning: A protection against rat hepatic ischemia-reperfusion injury. Hepatol 2000; 31:416-419.
30. Arai M et al. Contribution of adenosine A2 receptors and cyclic adenosine monophosphate to protective ischemic preconditioning of sinusoidal endothelial cells against storage/reperfusion injury in rat liver. Hepatol 2000; 32:297-302.
31. Yin DP et al. Protective effect of ischemic preconditioning on liver preservation-reperfusion injury in rats. Transplant 1998; 66: 152-157.
32. Peralta C et al. Hepatic preconditioning preserves energy metabolism during sustained ischemia. Am J Physiol 2000; 279:G163-G171.
33. Koti RS et al. The relationship of hepatic tissue oxygenation with nitric oxide metabolism in ischemic preconditioning of the liver. FASEB J 2002; 16:1654-1656.
34. O'Rourke B. Myocardial KATP channels in preconditioning. Circ Res. 2000; 87: 845-855.
35. Murphy E. Primary and secondary pathways in early preconditioning that converge on the mitochondria to produce cardioprotection. Circ. Res. 2004; 94:7-16.
36. Carini R et al. Ischemic preconditioning reduces Na+ accumulation and cell killing in isolated rat hepatocytes exposed to hypoxia. Hepatol 2000; 31:166-172.
37. Carini R et al. Stimulation of p38 MAP kinase reduces acidosis and Na+ overload in preconditioned hepatocytes. FEBS Lett 2001;491:180-183.
38. Carini R et al. Alteration of Na+ homeostasis as a critical step in the development of irreversible hepatocyte injury after adenosine triphosphate depletion. Hepatol 1995;21:1089-1098.
39. R.Carini et al. Preconditioning-induced cytoprotection in hepatocytes requires Ca2+-dependent fusion of lysosomes with plasmamembrane. Journal of Cell Science 2004;117:1065-1077.
40. Carini R et al. Intracellular Na+ accumulation and hepatocyte injury during cold storage. Transplant 1999; 68;249-319.
41. Carini R et al. Alteration of Na+ homeostasis in hepatocyte reoxygenation injury. Biochim Biophys Acta 2000; 1500;297-305.
42. Cavalieri B et al. Ischemic preconditioning attenuates the oxidant-dependent mechanisms of reperfusion cell damage and death in rat liver.Liver Transpl 2002;8:990-999.
43. Peralta C et al. Ischemic preconditioning: a defence mechanism against the reactive oxygen species generated after hepatic ischemic reperfusion. Transpant 2002; 73:1203-1211.
44. Peralta C et al. Protective effect of ischemic preconditioning on liver and lung injury induced by hepatic ischemia-reperfusion in the rat. Hepatol 1999; 30:1481-1489.
45. Peralta C et al. Strategies to modulate the deleterious effects of endothelin in hepatic ischemia-reperfusion. Transplant 2000; 70:1761-1770.
46. Serraffin A et al. Ischemic preconditioning affects interleukin release in fatty livers of rats undergoing ischemia/reperfusion. Hepatol 2004; 39:688-698.
47. Cutrin JC et al. Microvascular disfunction induced by reperfusion injury and protective effect of ischemic preconditioning. Free Rad Biol Med 2002; 33:1200-1208.
48. Peralta C et al. Preconditioning protects against systemic disorders associated with hepatic ischemia-reperfusion through blockade of tumor necrosis factor-induced P selectin up-regulation in the rat. Hepatol 2001; 33:100-113.
49. Carini R. et al. Signal pathway involved in the development of hypoxic preconditioning in rat hepatocytes. Hepatol. 2001; 33:131-139.
50. Peralta C. et al. Endogenous nitric oxide supplementation in hepatic ischemia-reperfusion injury in the rat. Trasplantation 2001; 71:529-536.
51. Carini R. et al. Nitric oxide as a mediator of hepatic ischemic preconditioning: intracellular mechanisms of hepatocyte protection against hypoxic injury. Free Rad Biol Med 2003; 34: 1047-105534.
52. Clavien PA. et al. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann. Surg. 2000; 232:155-162.
53. Clavien PA. et al. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning.
Ann. Surg. 2003; 238:843-850.

Parole Chiave

ISCHEMIA-RIOSSIGENAZIONE; IPOSSIA-RIOSSIGENAZIONE; PRECONDIZIONAMENTO; DANNO EPATICO; STRESS OSSIDATIVO; LESIONI MITOCONDRIALI; RISPOSTA INFIAMMATORIA; SEGNALI CITOPROTETTIVI; TRAPIANTO EPATICO